Ascend Laboratories, LLC

Frequent Recalls

9

Recalls

0

Units Recalled

0

Injuries

0

Deaths

Categories: Drug

2026-05-20 to 2026-08-05

Date	Source	Product	Brand	Severity	Units
2026-08-05	FDA Drug	Dabigatran Etexilate Capsules Recall (Aug 2026)	Ascend Laboratories, LLC	Class III	N/A
2026-08-05	FDA Drug	Dabigatran Etexilate Capsules Recall (Aug 2026)	Ascend Laboratories, LLC	Class III	N/A
2026-08-05	FDA Drug	Dabigatran Etexilate Capsules Recall (Aug 2026)	Ascend Laboratories, LLC	Class III	N/A
2026-07-29	FDA Drug	Dabigatran etexilate Capsules Recall (Jul 2026)	Ascend Laboratories, LLC	Class III	N/A
2026-07-29	FDA Drug	Dabigatran etexilate Capsules Recall (Jul 2026)	Ascend Laboratories, LLC	Class III	N/A
2026-07-29	FDA Drug	Amlodipine and Olmesartan Medoxomil Tablets Recall (Jul 2026)	Ascend Laboratories, LLC	Class II	N/A
2026-06-17	FDA Drug	Minocycline Hydrochloride Extended-Release Recall (Jun 2026)	Ascend Laboratories, LLC	Class II	N/A
2026-06-10	FDA Drug	Amlodipine and Olmesartan Medoxomil Tablets Recall (Jun 2026)	Ascend Laboratories, LLC	Class II	N/A
2026-05-20	FDA Drug	Ascend Laboratories LLC Recall (May 2026)	Ascend Laboratories, LLC	Class II	N/A

Ascend Laboratories, LLC Recalls | WatchRecall